Trial intelligence / Profile preview

Early administration of vitamin C in patients with sepsis or septic shock

2020-001862-12Phase 3Completed

Sponsor
UZ Leuven
Start
Feb 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in sepsis and septic shock comparing Vitamin C plus standard of care with Standard of care alone (2 arms). Primary endpoint: Clinical Severity. Started Feb 2021; status: completed.

02

Drugs

ascorbic acid
03

Conditions

sepsisseptic shock

Beyond the preview

Go deeper on 2020-001862-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-001862-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call